Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background: Cancer cells are described as an unregulated growth and spread of abnormal cells. Recently, cancer has become the most important major reason for deaths in the world. Methods: For anticancer activity, we have used the MTT method and determine the early/late apoptosis by flow cytometry. Results: The title compounds were procured by reacting 2-chloro-N-[4-(pyridin-4-yl)thiazol-2- yl]acetamide with some substituted piperazine derivatives. The in vitro anticancer activity of synthesized compounds was tested against C6 rat glioma cells and A549 human lung carcinoma cells. As a result, the compounds 3d, 3e, 3f and 3g have shown anticancer activity against both cell line. Conclusion: Specifically, compound 3f was determined as the most active compound against C6 rat glioma cells. Also, as understood, the core structure which is substituted with piperazine bridge, the heterocyclic aromatic derivatives are more active than phenyl or benzyl derivatives.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180815666180731122118
2019-05-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180815666180731122118
Loading

  • Article Type:
    Research Article
Keyword(s): acetamide; anticancer activity; azole; benzyl; phenyl; piperazine; Thiazole
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test